NIKKEI 225
26,945.67 -388.12 (-1.42%) HANG SENG
19,183.43 +182.72 (+0.96%) CRUDE OIL
67.15 -0.49 (-0.72%) GOLD FUTURES
1,986.60 +3.80 (+0.19%) DOW
32,244.58 +382.60 (+1.20%) Bitcoin GBP
22,670.42 +135.01 (+0.60%)
NVO Jan 2024 130.000 call
| Previous close | 23.00 |
| Open | 23.00 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 130.00 |
| Expiry date | 2024-01-19 |
| Day's range | 23.00 - 23.00 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Zacks
Universal Health (UHS) Up 26% in 6 Months: More Room to Run?
Universal Health (UHS) is well-poised for growth on the back of improved patient volumes, acquisitions and robust cash-generating abilities.
- Globe Newswire
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 20 March 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 28 billion to be executed during a 12-month period beginning 1 February 2023. Under the programme i
- Zacks
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?
Strong sales of key products like Keytruda and Gardasil and positive pipeline/regulatory developments should keep Merck's (MRK) stock afloat in 2023.
